How to Buy Aim Immunotech Stock
Aim Immunotech Inc
AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders.
Aim Immunotech stock last closed at $0.38, down 5% from the previous day, and has decreased 95.42% in one year. It has underperformed other stocks in the Biotechnology industry by 0.24 percentage points. Aim Immunotech stock is currently +80.95% from its 52-week low of $0.21, and -98.13% from its 52-week high of $20.35.
At the moment, there are 14.56M shares of AIM outstanding. The market cap of AIM is $5.53M. In the last 24 hours, 3.1M AIM shares were traded.
How to Buy Aim Immunotech Stock
Wondering how to invest in Aim Immunotech stock? Here's how.
- Decide where to buy Aim Immunotech stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Aim Immunotech stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Select your method of payment and add your details.
- Research Aim Immunotech stock: The Aim Immunotech ticker symbol is AIM. Is Aim Immunotech stock a good investment? Should you buy shares of AIM? How do AIM's underlying business fundamentals look? Do top analysts think Aim Immunotech is a good buy? Why has AIM's stock price moved recently? (Hint: Our stock analysis website can help you figure out if AIM is a good stock to buy).
- Execute your AIM purchase: Decide if you will purchase AIM shares at the current market price or use a limit order to purchase AIM stock at a given price.
- Monitor your AIM investment: Create a watchlist to track your position in Aim Immunotech shares.
Step 1: Decide where to buy Aim Immunotech stock
You will need a brokerage account to access the NYSEMKT market and buy AIM stock.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Tech to Healthcare, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal information so you are able to invest in AIM stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start your new brokerage account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have created your account on stock apps to use, you need to deposit funds:
Watch the tutorial below if you need help depositing funds into your investment account.
Step 4: Research Aim Immunotech stock
Once you have chosen the best place to buy Aim Immunotech stock, it's absolutely critical to evaluate their stock prior to investing, so you can comprehend the risk as well as the opportunity.
Aim Immunotech shares quick numbers
Aim Immunotech Overview
WallStreetZen was created to help average investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on AIM's stock page.
What is the fair value of AIM stock?
Investors use many financial metrics, analyses, models, and charts to gauge AIM's intrinsic value.
Using relative valuations metrics:
- AIM may be undervalued based on its P/B ratio of 2.6x, relative to Biotechnology industry P/B ratio of 4.95x
You can do more valuation analysis on AIM's stock here.
AIM Financials at a glance
Signs that AIM is financially healthy:
- There are more short-term assets than long-term liabilities on the AIM balance sheet.
- There are more short-term assets than short-term liabilities on the AIM balance sheet.
- AIM has $5.88M in cash and short term investments. This is enough to cover its annual cash burn of $11.29M.
Signs that AIM is not financially healthy:
- AIM profit margin has gone down from -10,416.4% to -14,123.4% in the past year.
- AIM has cash burn of 11294000. It does not have enough cash and short-term investments to cover this.
- AIM has a relatively high debt to equity ratio of 3.04.
- Total AIM debt is higher than 5 years ago, relative to shareholder equity.
Is AIM stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 1 Equities analysts who give forecasts on AIM, the consensus analyst rating on AIM is a Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Aim Immunotech stock forecast page.
AIM Momentum
AIM Performance Metrics
Last year, AIM revenue was $94.00k. In the past 5 year, AIM's revenue has gone up by -8.43% per year. This was slower than the Biotechnology industry average of 32.37%.
Dig into AIM's earnings and revenue performance here.
What are AIM insiders up to?
Over the past year, executives and large shareholders at AIM have bought more shares than they have sold.
David I. Chemerow, Director of AIM, was the latest AIM insider to buy. They bought $3,444.00 worth of AIM stock on Feb 5, 2026.
Research more about who owns AIM shares here.
Does AIM provide a stable income stream?
No, Aim Immunotech doesn't provide an income stream by paying out dividends.
What do other investors have to say about AIM?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your AIM purchase
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally the easiest way to buy. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact price limit, use a limit order.
Hit the Open button and your broker will place the order.
If you want more help with buying stocks on eToro, watch the helpful video below:
Step 6: Monitor your AIM investment
Now that you own some shares in AIM, you'll want to keep up with your company.
Make a watchlist to keep track of your AIM stock.
AIM Feed
How to Buy Stock in Aim Immunotech
To reiterate, here are the 6 steps to buy Aim Immunotech stock:
- Decide where to buy Aim Immunotech stock
- Open your brokerage account
- Deposit funds into your investment account
- Research Aim Immunotech stock
- Execute your AIM purchase
- Monitor your AIM investment
If you are looking for a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Aim Immunotech, get started below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.